These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11494046)

  • 1. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
    Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
    Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the UCHL1 gene in giant cell tumors of bone.
    Fellenberg J; Lehner B; Witte D
    Int J Cancer; 2010 Oct; 127(8):1804-12. PubMed ID: 20104524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells.
    Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J
    Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor.
    de Souza PE; Paim JF; Carvalhais JN; Gomez RS
    J Oral Pathol Med; 1999 Feb; 28(2):54-8. PubMed ID: 9950250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
    Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
    Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
    Tamborini E; Della Torre G; Lavarino C; Azzarelli A; Carpinelli P; Pierotti MA; Pilotti S
    Int J Cancer; 2001 Jun; 92(6):790-6. PubMed ID: 11351297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
    Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
    Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
    Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
    Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas.
    Broll R; Stark A; Windhövel U; Best R; Strik MW; Schimmelpenning H; Schwandner O; Kujath P; Bruch HP; Duchrow M
    Eur J Cancer; 1999 Jul; 35(7):1083-8. PubMed ID: 10533452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MDM2 during mammary tumorigenesis.
    Pinkas J; Naber SP; Butel JS; Medina D; Jerry DJ
    Int J Cancer; 1999 Apr; 81(2):292-8. PubMed ID: 10188733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
    Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
    J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
    Bartel F; Taylor AC; Taubert H; Harris LC
    Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
    Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
    Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.
    McCann AH; Kirley A; Carney DN; Corbally N; Magee HM; Keating G; Dervan PA
    Br J Cancer; 1995 May; 71(5):981-5. PubMed ID: 7734324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
    Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
    Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
    Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
    Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance.
    Millon R; Muller D; Schultz I; Salvi R; Ghnassia JP; Frebourg T; Wasylyk B; Abecassis J
    Oral Oncol; 2001 Dec; 37(8):620-31. PubMed ID: 11590071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
    Lonardo F; Ueda T; Huvos AG; Healey J; Ladanyi M
    Cancer; 1997 Apr; 79(8):1541-7. PubMed ID: 9118036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.